Spectrum Pharmaceuticals (SPPI) Sees Downside Action
Tweet
Share
E-mailGet Alerts SPPI Hot Sheet
Join SI Premium – FREE
Spectrum Pharmaceuticals, Inc. (Nasdaq: SPPI) is seeing a sharp downside move, triggering the short sale rule. Shares now sit down 8%. We have not seen any news to explain the downside action.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Nscale targets up to $3B in US IPO as soon as September - Bloomberg
- SEC accuses ex-BofA senior banker Satsky of insider trading - Bloomberg
- Citadel has shed over 80% of aggregate risk from Situational Awareness portfolio - CNBC
Create E-mail Alert Related Categories
Trader TalkSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
